세계의 조직 은행 시장은 CAGR 9.07%로 2025년 21억 2,800만 달러에서 2030년까지 32억 8,600만 달러로 성장할 것으로 예측됩니다.
세계의 조직 은행 시장은 의료 및 연구 용도로 신선한 표본이나 조직 수요 증가에 의해 큰 성장을 이루고 있습니다. 미래에 사용하기 위해 생물학적 표본을 수집 및 보존하는 조직 은행은 헬스케어, 연구, 특히 만성질환의 치료나 조직 재생의 진보를 지지하는 극히 중요한 존재입니다.
시장 성장 촉진요인
만성 질환 치료에서 조직 수요 증가
암과 같은 만성 질환의 치료에서 조직에 대한 필요성 증가는 세계 조직 은행 시장의 주요 촉진요인입니다. 이 은행은 미국 식품의약국(FDA)의 인정을 받고 있으며, 엄격한 규제 기준에 대한 적합을 보증하고 있습니다.
연구개발 진전
조직 재생과 만성 질환 치료에 초점을 맞춘 연구개발(R&D) 활동의 급증이 조직 은행 시장을 전진시키고 있습니다. Allergan 및 Hamilton사를 포함한 업계의 대기업은 조직공학에 많은 투자를 하고 조직 기반 치료법의 개발과 응용을 강화하고 있습니다.
지리적 전망
북미의 압도적 시장 점유율
북미는 세계 조직 은행 시장에서 가장 큰 점유율을 차지하고 있지만, 이것은 조직은행의 네트워크가 확립되고 있으며 조직 공학의 연구 개발이 활발한 것이 배경에 있습니다. 특히 미국은 고도의 헬스케어 인프라, FDA 인정의 조직은행, 정부의 지원 정책에 의해 리드하고 있습니다.
결론
세계 조직 은행 시장은 만성 질환 치료의 조직 요구 증가와 조직 공학 연구의 진보에 힘입어 지속적인 확대가 예상되고 있습니다. 의료 및 연구 분야에서의 조직은행에의 의존도가 높아짐에 따라, 시장은 성장 궤도를 유지해, 헬스케어 및 바이오 테크놀로지 업계의 이해 관계자에게 큰 기회를 제공할 것으로 예측됩니다.
어떤 용도로 사용됩니까?
업계 및 시장 인사이트, 사업 기회 평가, 제품 수요 예측, 시장 진출 전략, 지리적 확대, 설비 투자 결정, 규제 프레임워크과 영향, 신제품 개척, 경쟁의 영향
기업 프로파일
The tissue banking market is expected to grow from USD 2.128 billion in 2025 to USD 3.286 billion in 2030, at a CAGR of 9.07%.
The global tissue banking market is experiencing significant growth, driven by increasing demand for fresh specimens and tissues in medical and research applications. Tissue banks, which collect and store biological specimens for future use, are pivotal in supporting advancements in healthcare and research, particularly in the treatment of chronic diseases and tissue regeneration. This summary highlights key growth drivers and geographical trends based on market developments from 2024 onward, tailored for industry experts.
Market Growth Drivers
Rising Demand for Tissue in Chronic Disease Treatment
The escalating need for tissues to treat chronic conditions, such as cancer, is a primary driver of the global tissue banking market. Tissue banks provide critical specimens used in regenerative therapies, addressing the growing prevalence of chronic disorders. In the United States, the tissue banking network is robust, with approximately 58 accredited tissue banks, as reported by the American Association of Tissue Banks (AATB). These banks are certified by the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent regulatory standards. Blood tissues and cells dominate the market, reflecting their critical role in regenerative treatments. Government support, particularly in the U.S., further accelerates market expansion by promoting tissue bank utilization in healthcare.
Advancements in Research and Development
The surge in research and development (R&D) activities focused on tissue regeneration and chronic disease treatment is propelling the tissue banking market forward. Innovations, such as stem cell applications for developing various tissues, represent significant breakthroughs in the medical and health research sectors. Major industry players, including Allergan and Hamilton Companies, are investing heavily in tissue engineering, enhancing the development and application of tissue-based therapies. These R&D efforts are expanding the scope of tissue banks, enabling them to meet the growing demand for advanced therapeutic solutions and driving market growth.
Geographical Outlook
North America's Dominant Market Share
North America holds the largest share of the global tissue banking market, driven by a well-established network of tissue banks and robust R&D in tissue engineering. The region benefits from the presence of leading market players and a high incidence of chronic diseases, which increase the demand for tissue-based treatments. The U.S., in particular, leads due to its advanced healthcare infrastructure, FDA-accredited tissue banks, and supportive government policies. These factors collectively position North America as the epicenter of tissue banking innovation and market growth.
Conclusion
The global tissue banking market is poised for continued expansion, fueled by the rising need for tissues in chronic disease treatment and advancements in tissue engineering research. North America remains the market leader, supported by a strong network of accredited tissue banks and significant investments from key players. As the medical and research sectors increasingly rely on tissue banks, the market is expected to maintain its growth trajectory, offering substantial opportunities for stakeholders in the healthcare and biotechnology industries.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.
Tissue Banking Market Segmentation